Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned favorably in the biotechnology sector due to its innovative Enhanced Delivery Oligonucleotide platform, which has demonstrated significant potential in delivering therapeutics to critical tissue areas, including cardiac and central nervous systems. A strong pipeline, highlighted by key candidates such as PGN-EDO51 and PGN-EDODM1, suggests that should the company achieve a positive therapeutic profile with splicing correction exceeding 25%, the stock may see an appreciation of 40% to 100%, based on outlined scenarios. The company's reported 53.7% splicing correction not only surpasses competitors but also indicates a robust pathway for achieving meaningful clinical milestones and enhancing investor confidence in its valuation dynamics.

Bears say

The analysis indicates a negative outlook for PepGen's stock primarily due to multiple significant risks associated with its pipeline projects, particularly PGN-EDODM1. Key concerns include the potential for unexpected safety issues with the company's Enhanced Delivery Oligonucleotide platform, uncertainty surrounding the efficacy of PGN-EDODM1 compared to preclinical expectations, and an unclear regulatory path that may delay approval processes. Additionally, financial sustainability is at risk if the company fails to execute its development plans or secure necessary capital, which could further lead to declines in its market cap relative to competitive pressures.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Mar 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.